BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12360485)

  • 41. The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury.
    Nishio T; Koyama Y; Fuji H; Ishizuka K; Iwaisako K; Taura K; Hatano E; Brenner DA; Kisseleva T
    Biology (Basel); 2022 Oct; 11(11):. PubMed ID: 36358290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury.
    Owen A; Patten D; Vigneswara V; Frampton J; Newsome PN
    Stem Cells; 2022 Nov; 40(11):1056-1070. PubMed ID: 35999023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis.
    Huang Y; Zhang S; Weng JF; Huang D; Gu WL
    Open Med (Wars); 2022; 17(1):915-929. PubMed ID: 35647306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis.
    Almes M; Spraul A; Ruiz M; Girard M; Roquelaure B; Laborde N; Gottrand F; Turquet A; Lamireau T; Dabadie A; Bonneton M; Thebaut A; Rohmer B; Lacaille F; Broué P; Fabre A; Mention-Mulliez K; Bouligand J; Jacquemin E; Gonzales E
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
    van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
    JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.
    Fuchs CD; Trauner M
    Nat Rev Gastroenterol Hepatol; 2022 Jul; 19(7):432-450. PubMed ID: 35165436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis.
    Fuji H; Miller G; Nishio T; Koyama Y; Lam K; Zhang V; Loomba R; Brenner D; Kisseleva T
    Front Mol Biosci; 2021; 8():790032. PubMed ID: 34966784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice.
    Thibaut MM; Gillard J; Dolly A; Roumain M; Leclercq IA; Delzenne NM; Muccioli GG; Bindels LB
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A modified animal model of hepatic regeneration induced by hilar bile duct ligation.
    Li T; Chai Y; Chang P; Reng F; Xue Z; Zhang H; Lv Y; Hu L
    Sci Rep; 2021 Oct; 11(1):20201. PubMed ID: 34642435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. WNT7B Regulates Cholangiocyte Proliferation and Function During Murine Cholestasis.
    Kosar K; Cornuet P; Singh S; Lee E; Liu S; Gayden J; Sato T; Freyberg Z; Arteel G; Nejak-Bowen K
    Hepatol Commun; 2021 Dec; 5(12):2019-2034. PubMed ID: 34558852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway.
    Zhao J; Ran M; Yang T; Chen L; Ji P; Xu X; Zhang L; Sun S; Liu X; Zhou S; Zhou L; Zhang J
    Front Pharmacol; 2021; 12():686502. PubMed ID: 34366845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Radun R; Trauner M
    Semin Liver Dis; 2021 Nov; 41(4):461-475. PubMed ID: 34289507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling alcohol-associated liver disease in a human Liver-Chip.
    Nawroth JC; Petropolis DB; Manatakis DV; Maulana TI; Burchett G; Schlünder K; Witt A; Shukla A; Kodella K; Ronxhi J; Kulkarni G; Hamilton G; Seki E; Lu S; Karalis KC
    Cell Rep; 2021 Jul; 36(3):109393. PubMed ID: 34289365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rodent models of cholestatic liver disease: A practical guide for translational research.
    Gijbels E; Pieters A; De Muynck K; Vinken M; Devisscher L
    Liver Int; 2021 Apr; 41(4):656-682. PubMed ID: 33486884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.
    Angioni R; Calì B; Vigneswara V; Crescenzi M; Merino A; Sánchez-Rodríguez R; Liboni C; Hoogduijn MJ; Newsome PN; Muraca M; Russo FP; Viola A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis.
    Hohenester S; Kanitz V; Kremer AE; Paulusma CC; Wimmer R; Kuehn H; Denk G; Horst D; Elferink RO; Beuers U
    Cells; 2020 Jan; 9(2):. PubMed ID: 31979271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
    Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
    Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
    Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
    Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
    Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
    Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.
    Penman SL; Sharma P; Aerts H; Park BK; Weaver RJ; Chadwick AE
    Toxicol In Vitro; 2019 Dec; 61():104595. PubMed ID: 31288073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.